Microwave ablation combined with tirelizumab and fuquinitinib in the treatment of third-line and posterior advanced colorectal cancer patients: a single-arm, open, single-center clinical study
Ontology highlight
ABSTRACT: Interventions: Experimental group:Microwave ablation combined with tirelizumab and fuquintinib
Primary outcome(s): progression free survival
Study Design: Single arm
DISEASE(S): Colorectal Cancer
PROVIDER: 38520 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA